Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWeight loss injections licensed for home use in the UK are given once a week, by you, using a pre-filled pen. Mounjaro (tirzepatide) and Wegovy (semaglutide) are both prescription-only medicines that you inject at home after an initial clinical assessment — there is no clinic visit required. This guide walks through how the process works in practice, from your first consultation right through to building a weekly routine that fits around your life.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Before a pen is dispensed, a prescriber reviews your health history, current medicines, BMI and any weight-related conditions. That review is not a formality. It establishes which medicine suits you, what starting dose is appropriate, and flags anything that might make one option less suitable, for example, a history of pancreatitis, certain gastrointestinal conditions, or medicines whose absorption could be affected. The NHS tirzepatide page and the equivalent semaglutide guidance both list contraindications clearly, and a prescriber works through these with you.
Eligibility for either medicine covers adults with a BMI of 30 or above, or a BMI of 27 or above alongside a weight-related condition such as high blood pressure, high cholesterol or type 2 diabetes. Lower thresholds apply for some ethnic backgrounds under UK clinical guidance. BMI alone never guarantees supply, the prescriber sees the full picture. If you want to explore which injection might suit your situation, our page covering the three main weight loss injections available on this site is a useful starting point.
Once approved, your medicine is dispatched the same day (for orders placed before 12pm) and arrives the next working day. Both pens need refrigerating at 2–8°C when they arrive; check the Patient Information Leaflet supplied with your pen for the exact room-temperature window before use, it differs between products and we will not quote a figure here, because getting it wrong affects the medicine.
Each pen comes ready to use. You do not draw up a dose or attach a needle in the way older injectable medicines required. For Mounjaro's KwikPen, one pen contains four weekly doses; Wegovy comes as individual pens. The broad routine is the same for both: wash your hands, pick your injection site, clean the skin, press the pen against the site, activate it and hold it in place briefly while the dose delivers. Rotating between the abdomen, thigh and upper arm from week to week keeps skin healthy and absorption consistent.
Cleaning the skin beforehand with an alcohol swab is straightforward and takes seconds. Many people build the injection into an existing weekly anchor (Sunday evening after dinner, or Monday morning before the school run) so it becomes as unremarkable as any other routine. The needle is fine and short; most people find the physical sensation considerably less significant than they expected.
The starter dose for Mounjaro is 2.5mg; Wegovy's first step is 0.25mg. Neither of these opening doses is the therapeutic target, they exist to give your digestive system time to adapt, which is why the most common side effects (nausea, loose stools, indigestion) tend to be most noticeable in the first days after a dose increase, then settle. Your prescriber decides when and whether to move to the next dose level; you do not adjust the schedule yourself.
Most people experience some degree of nausea or digestive discomfort, especially in the first few weeks or after a dose step-up. Eating smaller portions, staying well hydrated and avoiding very fatty meals during the adjustment period all help. Fatigue and mild headaches are also common early on. These effects are well-documented across the clinical trials, the SURMOUNT-1 trial published in the New England Journal of Medicine tracked side effects in thousands of participants over 72 weeks, and gastrointestinal symptoms were the most frequently reported, with most described as mild to moderate and time-limited.
Certain symptoms warrant prompt medical attention rather than patience. Severe stomach pain that spreads to the back (with or without vomiting) should not be managed at home; it needs a same-day call to your GP or, if very sudden, urgent care. The MHRA highlighted acute pancreatitis as a known infrequent but potentially serious risk in a January 2026 Drug Safety Update for GLP-1 medicines; the regulator's Yellow Card scheme lets patients report any suspected side effects directly. Signs of a serious allergic reaction, gallbladder symptoms, or significant dehydration from repeated vomiting or diarrhoea also need professional review rather than waiting for your next check-in.
A good aftercare arrangement makes the difference here. Knowing you can contact a prescriber or pharmacist quickly (not days later) means you can raise concerns when they are still manageable, and if you are thinking ahead, our guide on whether and how you can come off weight loss injections is worth reading alongside your treatment plan. Our support team is available seven days a week for exactly these conversations.
Used injection pens and any detached needles are clinical waste. They cannot go in household recycling or general bins. A sharps container is the correct receptacle; once full, your local council or pharmacy will tell you how to arrange collection or drop-off. This is not a technicality, loose sharps in a bin bag are a hazard for anyone who handles your rubbish.
Store your pens away from children and from freezing temperatures (do not put them in the freezer). If a pen has been out of the fridge, refer to the leaflet rather than guessing how long it is still usable. And if you are ever unsure whether a dose was properly delivered, speak to a prescriber before attempting a second injection, the right answer varies by product and circumstance. For a broader look at what these treatments involve, our guide to how a weight loss injection works covers the landscape in more detail, and our FAQs address many of the questions that come up regularly once treatment is underway.
If you are ready to find out whether a home weight loss injection is clinically suitable for you, our page on what is the best injection for weight loss at home can help you compare your options before you speak to our prescribers through a free consultation, reviewed the same day by a GPhC-registered Independent Prescriber, with everything included in one transparent price if treatment goes ahead. You may also find it helpful to read about stem cell injection for weight loss if you are curious about how emerging approaches compare to the established options, and our overview of weight loss injections sets out the full range of treatments we offer in one place.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.